Cite

HARVARD Citation

    Konig, M. et al. (2020). Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Annals of the rheumatic diseases. 79 (10), pp. 1386-1388. [Online]. 
  
Back to record